We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$3.9B
AUM Growth
+$213M
Cap. Flow
+$75.8M
Cap. Flow %
1.94%
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 8.56%
3 Financials 6.53%
4 Communication Services 5.05%
5 Consumer Discretionary 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MVST icon
3276
Microvast
MVST
$302M
$14 ﹤0.01%
30
ALZN icon
3277
Alzamend Neuro
ALZN
$6.56M
0
AVTX icon
3278
Avalo Therapeutics
AVTX
$983M
$12 ﹤0.01%
1
HLX icon
3279
Helix Energy Solutions
HLX
$1.41B
$12 ﹤0.01%
1
WHWK
3280
Whitehawk Therapeutics
WHWK
$271M
$12 ﹤0.01%
8
-161,188
-100% -$299K
EHAB
3281
DELISTED
Enhabit
EHAB
$9 ﹤0.01%
1
DCTH icon
3282
Delcath Systems
DCTH
$524M
$8 ﹤0.01%
1
AAGR
3283
DELISTED
African Agriculture Holdings Inc
AAGR
$8 ﹤0.01%
30
KALA icon
3284
KALA BIO
KALA
$14.5M
0
VIRX
3285
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4 ﹤0.01%
8
AKTS
3286
DELISTED
Akoustis Technologies Inc
AKTS
$4 ﹤0.01%
30
CMAX
3287
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$3 ﹤0.01%
1
-6
-86% -$19
CNSP icon
3288
CNS Pharmaceuticals
CNSP
$7.86M
0
GWAV icon
3289
Greenwave Technology Solutions
GWAV
$3.47M
0
IMUX icon
3290
Immunic
IMUX
$195M
0
SEEL
3291
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
CCO icon
3292
Clear Channel Outdoor Holdings
CCO
$1.23B
$1 ﹤0.01%
1
CLOV icon
3293
Clover Health Investments
CLOV
$2.51B
$1 ﹤0.01%
1
-3,009
-100% -$2.7K
XXII
3294
22nd Century Group
XXII
$1.48M
0
TVRD
3295
Tvardi Therapeutics
TVRD
$23.4M
0
VRPX
3296
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
0
ABM icon
3297
ABM Industries
ABM
$2.84B
-11
Closed -$491
ACAD icon
3298
Acadia Pharmaceuticals
ACAD
$5.03B
-194
Closed -$3.59K
ACB
3299
Aurora Cannabis
ACB
$185M
-100
Closed -$439
AHRT
3300
AH Realty Trust
AHRT
$517M
-27
Closed -$281

Similar funds

Parallel Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
  • Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
  • Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
  • Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
  • Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
  • Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.

Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.